WHEN: Thursday, March 6, 2014, 1-3 pm EST
Online – The USA’s Energy Department’s Geothermal Technologies Office will host a webinar on a $10 million funding opportunity announcement for research and development that will advance Enhanced Geothermal Systems (EGS) in the United States.
EGS R&D Funding Opportunity.
This funding opportunity will support up to ten, three-year, collaborative research and development projects focused on applying innovative technologies to obtain and process high-precision data to better characterize and target potential EGS sites.
EGS research advances the Department’s goal of proving next-generation clean energy technologies by driving down the costs of commercial-scale EGS projects to achieve cost-competitive, renewable electricity for American homes and businesses.
In pursuit of this goal, the Department supports transformative research focused on removing obstacles to commercial EGS development to help industry better access, create, and sustain engineered reservoirs.
Read the full FOA on Exchange or register today for an informative webinar.
To generate renewable power around the clock, EGS projects produce energy from intensely hot rocks buried thousands of feet below the surface. Since EGS systems initially lack the permeability or fluid saturation found in naturally occurring hydrothermal systems, the working geothermal system must be “created” through rock stimulation.
Based on U.S. Geological Survey studies, this vast, untapped thermal resource could be greater than 100 gigawatts, enough to continuously power millions of American homes.
Learn more about the Department’s efforts to develop geothermal energy.
Register here for the Webinar
Available from several tumour tissue types
Abingdon, UK & Lake Forest CA, USA – AMSBIO has launched CancerSeq™, a new range of genetically characterised FFPE tissue samples.
CancerSeq™ samples are prepared from genomic DNA extracted from the FFPE tumour tissues and validated by Next Generation Sequencing using Illumina’s TruSeq Amplicon – Cancer Panel (TSACP).
Available as tissue slides and whole blocks, samples are delivered with the mutation and variation data for 48 cancer-related genes including BRAF, KRAS, EGFR, WALK and TP53. Continue reading
First EMPIR Call now open
Online — EURAMET announces the launch of the 2014 call for the following topic areas within the European Metrology Programme for Innovation and Research (EMPIR)
- Metrology for Industry
- Research Potential
EMPIR is currently a proposal of the European Commission being considered by the European Parliament and Council.
The Maxim/Dallas Glossary of EE Terms is a simple web page with links to the Glossary by number and alphabet.
There are several option, one, Index of Terms is a large page, 215K.
Another is All Terms and Definitions on a single web page; it is also large, 159K.
One has access to a search and an ability to suggest new terms.
A Range of Ready-to-use Products
Abingdon, UK & Lake Forest CA, USA — AMSBIO has introduced a range of ready-to-use human and mouse lentivirus products for miRNA and anti-miRNA expression (miRNA inhibition). Lentiviral expression vectors are the most effective vehicles for delivering genetic material to almost any mammalian cell—including non-dividing cells and whole model organisms.
miRNAs are endogenous non-coding RNAs that are highly conserved in mammals and that regulate gene expression post-transcriptionally through innate RNA interference mechanisms.